Although these data indicate that HIV-Tat, ATV, EFV, and RTV can modulate RyR2 in cardiac myocytes, additional studies in clinically relevant models must be conducted to determine if these drugs are capable of triggering arrhythmias and even SCD. The gene discussed is TAT; the disease is Arrhythmia.